| |
|
|
| Name: |
Kynam Capital Management LP |
| City: |
PRINCETON |
| State: |
NJ |
| Zip: |
08540 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
34 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
NTRA |
Natera, Inc. |
1 |
- |
$161.57 |
$165,106,000 |
1,167,570 |
14.13% |
-154,992,000 |
-854,528 |
0.944 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
2 |
- |
$0.00 |
$120,832,000 |
3,200,000 |
10.34% |
-70,458,000 |
863,204 |
2.344 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
3 |
- |
$22.11 |
$117,975,000 |
6,500,000 |
10.09% |
-9,998,000 |
1,435,793 |
8.81 |
Diagnostic Substances |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
4 |
- |
$9.00 |
$104,668,000 |
8,520,000 |
8.96% |
-7,966,000 |
0 |
9.062 |
N/A |
|
|
BCRX |
Biocryst Pharmaceuticals Inc |
5 |
- |
$9.02 |
$66,964,000 |
8,928,523 |
5.73% |
-1,358,000 |
-156,845 |
4.712 |
Biotechnology |
|
|
CGON |
CG Oncology, Inc |
6 |
- |
$26.68 |
$63,960,000 |
2,611,662 |
5.47% |
-8,305,000 |
91,957 |
3.957 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
7 |
- |
$15.23 |
$63,356,000 |
4,700,000 |
5.42% |
-408,000 |
1,373,738 |
5.222 |
N/A |
|
|
VERA |
Vera Therapeutics, Inc. |
8 |
- |
$0.00 |
$57,648,000 |
2,400,000 |
4.93% |
-4,007,000 |
942,090 |
4.377 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
9 |
- |
$7.41 |
$54,539,000 |
9,105,000 |
4.67% |
-16,480,000 |
0 |
6.98 |
N/A |
|
|
IMCR |
Immunocore Holdings Adr |
10 |
- |
$32.75 |
$50,308,000 |
1,695,576 |
4.3% |
14,154,000 |
470,000 |
3.391 |
N/A |
|
|
BEAM |
Beam Therapeutics Inc. |
11 |
- |
$19.88 |
$49,180,000 |
2,518,170 |
4.21% |
5,627,000 |
762,012 |
3.089 |
N/A |
|
|
WVE |
Wave Life Sciences Ltd. |
12 |
- |
$6.75 |
$39,588,000 |
4,899,497 |
3.39% |
-21,019,000 |
0 |
4.112 |
N/A |
|
|
DVAX |
Dynavax Technologies Corp |
13 |
- |
$10.16 |
$33,992,000 |
2,620,797 |
2.91% |
-49,790,000 |
-3,940,038 |
1.945 |
Drug Manufacturers - ... |
|
|
TVTX |
Travere Therapeutics, Inc |
14 |
- |
$14.84 |
$32,305,000 |
1,802,750 |
2.76% |
901,000 |
0 |
2.012 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
15 |
- |
$0.00 |
$22,376,000 |
2,406,067 |
1.91% |
15,002,000 |
1,875,589 |
4.562 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
16 |
- |
$3.74 |
$22,374,000 |
4,994,090 |
1.91% |
-10,837,000 |
0 |
11.307 |
N/A |
|
|
LEGN |
Churchill Cap Corp Iii |
17 |
New |
$35.91 |
$20,697,000 |
610,000 |
1.77% |
20,697,000 |
610,000 |
0.472 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
18 |
- |
$0.00 |
$17,703,000 |
2,338,629 |
1.51% |
2,445,000 |
1,085,891 |
0.537 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
19 |
New |
$0.00 |
$9,504,000 |
800,000 |
0.81% |
9,504,000 |
800,000 |
1.127 |
N/A |
|
|
LQDA |
Liquidia Technologies Inc |
20 |
- |
$12.06 |
$9,349,000 |
633,802 |
0.8% |
-17,303,000 |
-1,632,526 |
0.825 |
N/A |
|
|
IRWD |
Ironwood Pharmaceuticals Inc |
21 |
- |
$0.74 |
$8,560,000 |
5,822,938 |
0.73% |
-12,197,000 |
1,137,375 |
3.351 |
Medical Laboratories ... |
|
|
RLAY |
Relay Therapeutics, Inc. |
22 |
- |
$3.60 |
$8,026,000 |
3,063,292 |
0.69% |
3,906,000 |
2,063,292 |
1.834 |
N/A |
|
|
GERN |
Geron Corporation |
23 |
New |
$1.40 |
$5,819,000 |
3,659,526 |
0.5% |
5,819,000 |
3,659,526 |
0.674 |
Drug Manufacturers - ... |
|
|
AMRN |
Amarin Corp Plc |
24 |
- |
$0.45 |
$5,563,000 |
12,414,628 |
0.48% |
-458,000 |
0 |
3.173 |
Drug Manufacturers - ... |
|
|
BNR |
Burning Rock Biotech Ltd |
25 |
- |
$0.00 |
$4,380,000 |
994,883 |
0.37% |
-2,335,000 |
0 |
0.977 |
N/A |
|
|
STRO |
Sutro Biopharma Inc |
26 |
- |
$0.76 |
$3,540,000 |
5,441,447 |
0.3% |
-3,160,000 |
1,800,000 |
6.639 |
N/A |
|
|
DSGN |
Design Therapeutics, Inc. |
27 |
New |
$0.00 |
$3,490,000 |
904,017 |
0.3% |
3,490,000 |
904,017 |
1.625 |
N/A |
|
|
CRBU |
Caribou Biosciences, Inc. |
28 |
- |
$1.37 |
$2,985,000 |
3,269,147 |
0.26% |
-841,000 |
863,000 |
3.697 |
N/A |
|
|
PRQR |
ProQR Therapeutics N.V. |
29 |
- |
$2.13 |
$2,328,000 |
1,750,000 |
0.2% |
-2,310,000 |
0 |
3.49 |
N/A |
|
|
ELYM |
Eliem Therapeutics, Inc. |
30 |
- |
$0.00 |
$1,277,000 |
1,047,000 |
0.11% |
292,000 |
500,000 |
1.561 |
N/A |
|
|
URGN |
Urogen Pharma Ltd. |
31 |
New |
$12.96 |
$277,000 |
25,000 |
0.02% |
277,000 |
25,000 |
0.059 |
N/A |
|
|
PTGX |
Protagonist Therapeutics, Inc |
34 |
Closed |
$50.69 |
$0 |
0 |
0% |
-15,085,000 |
-390,792 |
0 |
N/A |
|
|
SLRN |
Acelyrin, Inc. |
33 |
Closed |
$2.27 |
$0 |
0 |
0% |
-2,661,000 |
-847,366 |
0 |
N/A |
|
|
TSVT |
2seventy Bio, Inc. |
32 |
Closed |
$0.00 |
$0 |
0 |
0% |
-17,504,000 |
-5,953,825 |
0 |
N/A |
|
